A5009735630- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Economic Sanctions and International Relations
- Economic, Social, and Public Health Issues in Russia and Globally
- Healthcare Systems and Reforms
- Hepatitis Viruses Studies and Epidemiology
- Global Health Care Issues
- Blood donation and transfusion practices
- Long-Term Effects of COVID-19
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare cost, quality, practices
- Innovations in Medical Education
- Medical Education and Admissions
- Global Public Health Policies and Epidemiology
- Chronic Disease Management Strategies
- Pharmaceutical Economics and Policy
- SARS-CoV-2 and COVID-19 Research
- Innovation and Socioeconomic Development
- Dental Education, Practice, Research
- Healthcare Systems and Public Health
- COVID-19 Clinical Research Studies
National Center for Disease Control and Public Health
2023-2025
Ministry of Labour, Health and Social Affairs
2019-2024
AID Atlanta
2024
World Health Organization
2022
Federal Ministry of Labour and Social Affairs
2021
Hepatitis B and hepatitis C are leading causes of cirrhosis liver cancer caused 1.3 million deaths worldwide in 2022.Hepatitis is preventable with vaccination, curable direct-acting antivirals.In 2015, collaboration CDC other partners, Georgia, a country at the intersection Europe Asia, launched elimination program to reduce prevalence chronic C; that time, was 5.4%, more than five times global average 1.0%.In 2016, World Health Assembly endorsed goal for viral as public health problem by...
Background: We evaluated the cost and cost-effectiveness of alternative screening pathways during 2018-2022 within Georgia's hepatitis C elimination program, which started in 2015. Methods: calculated patient-level costs (2022 USD$) treatment with centralized decentralized diagnostic testing hospitals, primary healthcare (PHC), harm reduction providers (HRP), or specialized (SP) from reimbursement records including value donated direct-acting antivirals (DAAs). model case-finding,...
BACKGROUND: Patient-centred care along with optimal financing of inpatient and outpatient services are the main priorities Georgia National TB Programme (NTP). This paper presents diagnostics treatment unit cost, their comparison NTP tariffs how study findings informed policy. METHODS: Top-down (TD) bottom-up (BU) mean costs for interventions by episode were calculated. TD compared tariffs, variations in these cost composition between public private facilities was assessed. RESULTS:...
Content available: Audio Recording.
Continuing medical education (CME) is a vital component of health systems. Setting up CME system complex task, requiring involvement stakeholders including educators, learners, institutions and policy makers. The aim the study was to conduct qualitative research involving multiple explore perceived effectiveness shortcomings in Georgia, its place potential means improving it.This study. All data were collected using semistructured individual interviews. questions derived from relevant...
Enhancing digital health governance is critical to healthcare systems in low-income and middle-income countries. However, implementing governance-enhancing reforms these countries often challenging due the multiplicity of external players insufficient operational guidance that accessible. Using data from desktop research, in-depth interviews, focus group discussions three stakeholder workshops, this paper aims provide insights into Georgia's experience advancing reforms. It reveals how...
Abstract Background and Aims In 2015, the country of Georgia launched an elimination program aiming to reduce prevalence Hepatitis C virus (HCV) infection by 90% from 5.4% (~150 000 people). During first 2.5 years program, 770 832 people were screened, 48 575 diagnosed with active HCV infection, 41 483 patients treated direct‐acting antiviral (DAA)‐based regimens, a >95% cure rate. Methods We modelled incremental cost‐effectiveness ratio (ICER) screening, diagnosis treatment between April...